误诊为急性共同性内斜视的眼肌型重症肌无力1例
Ocular Myasthenia Gravis Misdiagnosed as Acute Acquired Comitant Esotropia: A Case Report
DOI: 10.12677/acm.2025.15123502, PDF,   
作者: 陈佳卿*, 梁媛婷, 周 清:暨南大学附属第一医院眼科,广东 广州;李超群:中山大学中山眼科中心,广东 广州;陈 剑#:暨南大学眼科研究所,广东 广州
关键词: 急性共同性内斜视眼肌型重症肌无力肉毒毒素Acute Acquired Comitant Esotropia Ocular Myasthenia Gravis Botulinum Toxin
摘要: 本文报道一例误诊为急性共同性内斜视(Acute Acquired Comitant Esotropia, AACE)的眼肌型重症肌无力(Ocular Myasthenia Gravis, OMG)病例:7岁男性患儿主诉双眼交替性内斜5个月,外院按AACE行双眼内直肌肉毒毒素注射后出现右眼上睑下垂及左眼外转受限。我院查体见波动性睑裂高度及眼球运动障碍,新斯的明试验阳性。虽血清抗AChR、MuSK、LRP4等多种抗体及重复神经电刺激检查均为阴性,但根据典型临床表现及药理学试验确诊为OMG。予溴吡斯的明及小剂量糖皮质激素治疗后症状缓解。本病例提示:诊断AACE前需详细评估眼球运动功能及症状波动性,以排除OMG。对于表现为急性内斜视的患儿,在排除神经肌肉疾病前应避免肉毒毒素注射,新斯的明试验具有关键诊断价值。
Abstract: This article reports a case of ocular myasthenia gravis (OMG) misdiagnosed as acute acquired comitant esotropia (AACE). A 7-year-old male patient presented with a 5-month history of alternating esotropia. Following a diagnosis of AACE at an external hospital, he received bilateral medial rectus muscle botulinum toxin injections, after which he developed right ptosis and limited left eye abduction. Examination at our hospital revealed fluctuating palpebral fissure height and impaired ocular motility. The neostigmine test was positive. Despite negative results for multiple serum antibodies (including anti-AChR, MuSK, and LRP4) and a repetitive nerve stimulation test, the patient was diagnosed with OMG based on characteristic clinical manifestations and pharmacological testing. Symptoms improved following treatment with pyridostigmine and low-dose glucocorticoids. This case highlights that a detailed assessment of ocular motility and symptom fluctuation is essential prior to diagnosing AACE to exclude OMG. In children presenting with acute esotropia, botulinum toxin injection should be avoided prior to excluding neuromuscular disorders, and the neostigmine test holds critical diagnostic value.
文章引用:陈佳卿, 梁媛婷, 李超群, 周清, 陈剑. 误诊为急性共同性内斜视的眼肌型重症肌无力1例[J]. 临床医学进展, 2025, 15(12): 1049-1054. https://doi.org/10.12677/acm.2025.15123502

参考文献

[1] Burian, H.M. and Miller, J.E. (1958) Comitant Convergent Strabismus with Acute Onset. American Journal of Ophthalmology, 45, 55-64. [Google Scholar] [CrossRef] [PubMed]
[2] Krenn, M., Grisold, A., Wohlfarth, P., Rath, J., Cetin, H., Koneczny, I., et al. (2020) Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments. Frontiers in Molecular Neuroscience, 13, Article No. 156. [Google Scholar] [CrossRef] [PubMed]
[3] 肖哲曼, 董红娟, 卢祖能. 肉毒毒素局部注射的远隔效应:病理生理机制及电生理学评价[J]. 临床神经电生理学杂志, 2003, 12(2): 116-118.
[4] Timmermans, G., Depierreux, F., Wang, F., Hansen, I. and Maquet, P. (2019) Cosmetic Injection of Botulinum Toxin Unmasking Subclinical Myasthenia Gravis: A Case Report and Literature Review. Case Reports in Neurology, 11, 244-251. [Google Scholar] [CrossRef] [PubMed]
[5] Durmuş Tekçe, H., Deymeer, F., Oflazer Serdaroğlu, P. and Parman, Y. (2016) Myasthenia Gravis after Botulinum Toxin Type a Injection. Turkish Journal of Neurology, 22, 143-144. [Google Scholar] [CrossRef
[6] Chegini, A. (2017) Therapeutic Plasma Exchange in a Rare Case Myasthenic Crisis after Botox Injection. Atherosclerosis Supplements, 30, 283-285. [Google Scholar] [CrossRef] [PubMed]
[7] 中华医学会神经病学分会神经免疫学组. 中国重症肌无力诊断和治疗指南(2025版) [J]. 中华神经科杂志, 2025, 58(7): 721-741.
[8] Lu, C., Yang, Y., Dong, Y., Tang, T., Chen, J., Wang, Y., et al. (2025) Anti-Acetylcholine Receptor Antibodies in Tear for the Diagnosis of Ocular Myasthenia Gravis. American Journal of Ophthalmology, 277, 139-147. [Google Scholar] [CrossRef] [PubMed]
[9] Benatar, M. and Kaminski, H. (2012) Medical and Surgical Treatment for Ocular Myasthenia. Cochrane Database of Systematic Reviews, 12, CD005081. [Google Scholar] [CrossRef] [PubMed]
[10] 彭丹陶, 许贤豪, 佘子瑜. 新斯的明试验改良结果判定法研究[J]. 中国神经免疫学和神经病学杂志, 2007, 14(1): 1-3.
[11] 孙铭祺, 底煜. 急性共同性内斜视研究进展[J]. 中国斜视与小儿眼科杂志, 2025, 33(1): 44-47.